Skip to content

Effects of Creatine and Rehabilitation Programin Athletes With Patellar Tendinopathy

Effects of Creatine Supplementation in Combination With a Rehabilitation Program Physical in Athletes With Patellar Tendinopathy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06482619
Acronym
CREATINE_TEN
Enrollment
26
Registered
2024-07-01
Start date
2021-01-01
Completion date
2023-11-01
Last updated
2024-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Creatine, Patellar Tendinopathy

Keywords

Ergogenic aid, Dietary, Injury, Nutrition, Sport Nutrition

Brief summary

The aim of this study are to analyze the effect of creatine ingestion in pain, histological properties of the tendon, body composition, strength and vertical jump performance in athletes with patellar tendinopathy that follow a physical rehabilitation program that include eccentric exercise combined with stretching and extracorporeal shock wave therapy.

Detailed description

Nutrition could play an important role in the rehabilitation from sport injuries. This afirmation is based on studies that analyze the impact of different dietary supplements along immobilization periods, stablishing that creatine, leucine and omega-3 fatty acid supplementation could ameliorate muscle loss, while creatine could potentiate the hypertrophy along the rehabilitation process. For this reason, the aim of this study are to analyze the effect of creatine ingestion in pain, histological properties of the tendon, body composition, strength and vertical jump performance in athletes with patellar tendinopathy that follow a physical rehabilitation program that include eccentric exercise combined with stretching and extracorporeal shock wave therapy.

Interventions

DIETARY_SUPPLEMENTCreatine supplementation

The supplements were provided in capsules of 1 g of red color not transparent Guinama S.L.U, 0044634, La Pobla de Valbona, Spain) which were prepared with a Capsunorm 2000 semi-automatic manual capsule filling machine (Miranda del Ebro, Spain). Capsules contained creatine monohidrate (Creapure, Crown Sport Nutrition, Arnedo, Spain)

DIETARY_SUPPLEMENTPlacebo

The supplements were provided in capsules of 1 g of red color not transparent Guinama S.L.U, 0044634, La Pobla de Valbona, Spain) which were prepared with a Capsunorm 2000 semi-automatic manual capsule filling machine (Miranda del Ebro, Spain). Capsules contained placebo (i.e., sucrose)

Sponsors

Universidad de Córdoba
CollaboratorOTHER
University of Bologna
CollaboratorOTHER
Technical University of Madrid
CollaboratorOTHER
Lavras University
CollaboratorUNKNOWN
Universidad Pontificia Comillas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

A researcher who did not have any contact with the participants and the physiotherapist who performed the physical rehabilitation intervention and the assessments randomly divided the participants to the creatine or placebo groups in a computerized random list with a 1:1 allocation using the software Research Randomizer (www.randomizer.org).

Eligibility

Sex/Gender
MALE
Age
18 Years to 49 Years
Healthy volunteers
No

Inclusion criteria

* Athletes diagnosed with patellar tendinopathy by sport medicine doctor. * Age (\>18 years and \<49 years). * To be federated in a sport modality that involves high repetitive impact in the knee; iii) to train more than 3 sessions weekly. * Not having undergone knee surgery. * Not having undergone any infiltration of analgesics or platelet-rich plasma during the last year. * Not intake any sport performance supplement in the previous year; * Smoker person.

Exclusion criteria

* Not being diagnosed with patellar tendinopathy by a doctor * Age (\<18 years and \> 50 years). * Involved in a sport modality without high repetitive impacts during sports activity.

Design outcomes

Primary

MeasureTime frameDescription
Pain evaluation8-weeksFor assessing pain, the Victorian Institute for Sports Assessment - Patella (VISA - P), the most widely used patient-reported outcome measure (including symptom severity), was administered . The VISA - P will be scored with a maximum of 100 points and the higher scores indicate better function, and it shows sensible to identify improvements in therapeutic interventions among patients with tendinopathies.
Tendon thickness.8-weeksThickness Tendon of the injuried knee/s was analyzed with ultrasound (GE VENUE 40, Portable Ultrasound, CA, USA), and a linear translator. Participants were positioned supine with a 30º knee flexion (using a roller under the knees), reducing the locking of the patella in the femur as in full extension. Ultrasound gel was applied and evaluated by placing the probe longitudinally; in pathological tendons it is the only way to determine the distance of the measurement point from the insertion of the tendon. Thus, subsequent measurements were always made from the same point.

Secondary

MeasureTime frameDescription
Neuromuscular function8-weeksParticipants performed a neuromuscular test battery consisted in measuring vertical jump capacity (i.e., countermovement jump) and knee extension muscle strength muscular strength in a knee extension machine (Selection Leg Extension, Technogym, Cesena, Italy) with a 5 maximum number of repetitions (5-RM)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026